Nancy Davidson

CIK 2002946 · View on SEC EDGAR ↗

Insider

First SEC filing: Dec. 8, 2023 · Latest: Dec. 8, 2023

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 2 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Dec. 10, 2024 ZYME A 31,000 31,000 Direct Acquired (price as of 2026-08-19)
Dec. 7, 2023 ZYME A 74,000 74,000 Direct Acquired (price as of 2026-08-19)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Dec. 10, 2024 ZYME Stock Option (Right to Buy) Common Stock (31,000) $13.06 Dec. 9, 2034 31,000 Acquired
Dec. 7, 2023 ZYME Stock Option (Right to Buy) Common Stock (74,000) $9.55 Dec. 6, 2033 74,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 2 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Dec. 8, 2023 ZYME No securities are beneficially owned 0 Direct
Dec. 8, 2023 ZYME No securities are beneficially owned→ Not applicable (0) 0 Direct